Raphael Dolin

14.5k total citations · 2 hit papers
152 papers, 8.5k citations indexed

About

Raphael Dolin is a scholar working on Epidemiology, Infectious Diseases and Virology. According to data from OpenAlex, Raphael Dolin has authored 152 papers receiving a total of 8.5k indexed citations (citations by other indexed papers that have themselves been cited), including 80 papers in Epidemiology, 71 papers in Infectious Diseases and 45 papers in Virology. Recurrent topics in Raphael Dolin's work include HIV Research and Treatment (37 papers), Viral gastroenteritis research and epidemiology (34 papers) and Herpesvirus Infections and Treatments (27 papers). Raphael Dolin is often cited by papers focused on HIV Research and Treatment (37 papers), Viral gastroenteritis research and epidemiology (34 papers) and Herpesvirus Infections and Treatments (27 papers). Raphael Dolin collaborates with scholars based in United States, Canada and Germany. Raphael Dolin's co-authors include Richard G. Wyatt, Albert Z. Kapikian, Robert M. Chanock, Thomas S. Thornhill, Richard C. Reichman, H P Madore, Anthony R. Kalica, Charles A. Alford, Richard J. Whitley and George J. Galasso and has published in prestigious journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Raphael Dolin

150 papers receiving 7.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Visualization by Immune Electron Microscopy of a 27-nm Particle Associated with Acute Infectious Nonbacterial Gastroenteritis

1972 753 citations Albert Z. Kapikian, Raphael Dolin et al. profile →
Adenine Arabinoside Therapy of Biopsy-Proved Herpes Simplex Encephalitis

1977 498 citations Raphael Dolin et al. profile →

Peers

Countries citing papers authored by Raphael Dolin

Since Specialization

Citations

This map shows the geographic impact of Raphael Dolin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raphael Dolin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raphael Dolin more than expected).

Fields of papers citing papers by Raphael Dolin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raphael Dolin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raphael Dolin. The network helps show where Raphael Dolin may publish in the future.

Co-authorship network of co-authors of Raphael Dolin

This figure shows the co-authorship network connecting the top 25 collaborators of Raphael Dolin. A scholar is included among the top collaborators of Raphael Dolin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raphael Dolin. Raphael Dolin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Characterization of Humoral and Cellular Immune Responses Elicited by a Recombinant Adenovirus Serotype 26 HIV-1 Env Vaccine in Healthy Adults (IPCAVD 001) 2012 ·The Journal of Infectious Diseases ·Dan H. Barouch, Jinyan Liu, Lauren Peter, Peter Abbink, M. Justin Iampietro, Ann Cheung, Galit Alter, Amy W. Chung, (unknown), Nicole Frahm, M. Juliana McElrath, Holger Wenschuh, Ulf Reimer, Michael S. Seaman, Maria Grazia Pau, Mo Weijtens, Jaap Goudsmit, Stephen R. Walsh, Raphael Dolin, Lindsey R. Baden	75
2	Impact of anti-orthopoxvirus neutralizing antibodies induced by a heterologous prime-boost HIV-1 vaccine on insert-specific immune responses 2012 ·Vaccine ·Stephen R. Walsh, Michael S. Seaman, Lauren E. Grandpre, (unknown), Katherine E. Yanosick, Barbara Metch, Michael C. Keefer, Raphael Dolin, Lindsey R. Baden	8
3	Vaccinia viruses: vaccines against smallpox and vectors against infectious diseases and tumors 2011 ·Expert Review of Vaccines ·Stephen R. Walsh, Raphael Dolin	68
4	Effect of Vaccination with Modified Vaccinia Ankara (ACAM3000) on Subsequent Challenge with Dryvax 2010 ·The Journal of Infectious Diseases ·Michael S. Seaman, Marissa B. Wilck, Lindsey R. Baden, Stephen R. Walsh, Lauren E. Grandpre, (unknown), (unknown), (unknown), Jane A. Kleinjan, Kristen E. Stevenson, Haesook T. Kim, Raphael Dolin	26
5	Safety and Immunogenicity of Modified Vaccinia Ankara (ACAM3000): Effect of Dose and Route of Administration 2010 ·The Journal of Infectious Diseases ·Marissa B. Wilck, Michael S. Seaman, Lindsey R. Baden, Stephen R. Walsh, Lauren E. Grandpre, (unknown), (unknown), Jane A. Kleinjan, (unknown), Kristen E. Stevenson, Haesook T. Kim, Raphael Dolin	55
6	Immunogenicity of recombinant Modified Vaccinia Ankara following a single or multi-dose vaccine regimen in rhesus monkeys 2009 ·Vaccine ·Lauren E. Grandpre, Jonathan S. Duke‐Cohan, Bonnie A. Ewald, (unknown), Dan H. Barouch, Norman L. Letvin, Ellis L. Reinherz, Lindsey R. Baden, Raphael Dolin, Michael S. Seaman	18
7	HIV VACCINES FOR PREVENTION OF INFECTION AND DISEASE IN HUMANS 2000 ·Infectious Disease Clinics of North America ·Raphael Dolin	7
8	Viral infections of the respiratory tract 1999 ·Marcel Dekker eBooks ·Raphael Dolin, Peter F. Wright	20
9	Predictors of Survival in HIV-Infected Persons With 50 or Fewer CD4 Cells/mm3 1997 ·Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology ·Cathie Spino, James O. Kahn, Raphael Dolin, John Phair	17
10	Immunization with Envelope Subunit Vaccine Products Elicits Neutralizing Antibodies against Laboratory-Adapted but Not Primary Isolates of Human Immunodeficiency Virus Type 1 1996 ·The Journal of Infectious Diseases ·John R. Mascola, S W Snyder, O. S. Weislow, Solomon Belay, Robert B. Belshe, David H. Schwartz, M L Clements, Raphael Dolin, Barney S. Graham, Geoffrey J. Gorse, M. C. Keefer, M. Juliana McElrath, Mary Clare Walker, K Wagner, John G. McNeil, Francine E. McCutchan, Donald S. Burke, (unknown)	354
11	Prognostic Value of Plasma Human Immunodeficiency Virus Type 1 (HIV-l) RNA Levels in Patients with Advanced HIV-l Disease and with Little or No Prior Zidovudine Therapy 1996 ·The Journal of Infectious Diseases ·Seth L. Welles, J. Brooks Jackson, Belinda Yen‐Lieberman, Lisa M. Demeter, Anthony J. Japour, Laura Smeaton, Victoria A. Johnson, Daniel R. Kuritzkes, Richard T. D’Aquila, (unknown), Douglas D. Richman, Richard C. Reichman, Margaret A. Fischl, Raphael Dolin, Robert W. Coombs, James O. Kahn, C. McLaren, John A. Todd, Shirley Kwok, Clyde S. Crumpacker	74
12	Development of Zidovudine Resistance Mutations in Patients Receiving Prolonged Didanosine Monotherapy 1995 ·The Journal of Infectious Diseases ·Lisa M. Demeter, (unknown), Gene D. Morse, Raphael Dolin, (unknown), Peter Gerondelis, Richard C. Reichman	32
13	Determinants Of Antibody Response After Recombinant Gp160 Boosting In Vaccinia-Naive Volunteers Primed With Gp160-Recombinant Vaccinia Virus 1994 ·The Journal of Infectious Diseases ·Barney S. Graham, Geoffrey J. Gorse, David H. Schwartz, M. C. Keefer, M. Juliana McElrath, Thomas J. Matthews, Peter F. Wright, Robert B. Belshe, M L Clements, Raphael Dolin, Lawrence Corey, Dani P. Bolognesi, D Stablein, Joy Esterlitz, Shiu-Lok Hu, Gale Smith	29
14	Studies of High Doses of a Human Immunodeficiency Virus Type 1 Recombinant Glycoprotein 160 Candidate Vaccine in HIV Type 1-Seronegative Humans 1994 ·AIDS Research and Human Retroviruses ·Michael C. Keefer, Barney S. Graham, Robert B. Belshe, David H. Schwartz, Lawrence Corey, Dani P. Bolognesi, Donald M. Stablein, David C. Montefiori, (unknown), M L Clements, Geoffrey J. Gorse, Peter F. Wright, Thomas J. Matthews, Gale Smith, Dale N. Lawrence, Raphael Dolin	46
15	Persisting Human Immunodeficiency Virus Type 1 gp160-Specific Human T Lymphocyte Responses Including CD8+ Cytotoxic Activity after Receipt of Envelope Vaccines 1993 ·The Journal of Infectious Diseases ·N Daher, M. C. Keefer, Richard C. Reichman, Raphael Dolin, Norbert J. Roberts	33
16	Field Trial of Rhesus Rotavirus or Human-Rhesus Rotavirus Reassortant Vaccine of VP7 Serotype 3 or 1 Specificity in Infants 1992 ·The Journal of Infectious Diseases ·H P Madore, Cynthia Christy, Michael E. Pichichero, (unknown), (unknown), (unknown), Albert Z. Kapikian, Raphael Dolin, (unknown)	52
17	Relationship between Dideoxyinosine Exposure, CD4 Counts, and p24 Antigen Levels in Human Immunodeficiency Virus Infection 1992 ·Annals of Internal Medicine ·George L. Drusano, Geoffrey J. Yuen, John S. Lambert, Mindell Seidlin, Raphael Dolin, Fred Valentine	43
18	Pharmacokinetics of didanosine in patients with acquired immunodeficiency syndrome or acquired immunodeficiency syndrome—related complex 1991 ·Clinical Pharmacology & Therapeutics ·Catherine A. Knupp, Wen Chyi Shyu, Raphael Dolin, Fred Valentine, C. McLaren, R. Russell Martin, Kenneth A. Pittman, Rashmi H. Barbhaiya	89
19	Treatment of Recurrent Genital Herpes Simplex Infections with Oral Acyclovir. A Controlled Trial 1984 ·Obstetrical & Gynecological Survey ·Richard C. Reichman, Gary J. Badger, Grégory Mertz, Lawrence Corey, Douglas D. Richman, James D. Connor, (unknown), (unknown), Michael N. Oxman, (unknown), (unknown), J. Portnoy, (unknown), Ronald E. Keeney, Takamaru Ashikaga, Raphael Dolin	3
20	Norwalk Agent-like Particles Associated with Gastroenteritis in Human Beings 1978 ·Journal of the American Veterinary Medical Association ·Raphael Dolin	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact